The antiplatelet effect of atorvastatin in patients with acute coronary syndrome depends on the hs-CRP level

References

• Macchi L, Christiaens L, Brabant S, Sorel N, Allal J, Mauco G, et al. Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate. Thromb Res. 2002; 107: 45–9
   PubMed Web of Science ®Google Scholar
• Hankey GJ, Eikelboom JW. Aspirin resistance. Lancet 2006; 367: 606–17
   PubMed Web of Science ®Google Scholar
• Gum PA, Kottke-Marchant K, Welsh PA, White J, Topol EJ. A prospective, blinded determination of the nature al history of aspirin resistance among stable patients with cardiovascular disease. J Am Coll Cardiol. 2003; 41: 961–5
   PubMed Web of Science ®Google Scholar
• Maree AO, Fitzgerald DJ. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease. Circulation 2007; 115: 2196–207
   PubMed Web of Science ®Google Scholar
• Hovens MMC, Snoep JD, Eikenboom JCJ, Born JG, Mertens BJA., Huisman MV. Prevalence of persistent platelet reactivity despite use of aspirin: A systematic review. Am Heart J. 2007; 153: 175–81
   PubMed Web of Science ®Google Scholar
• Schroeder WS, Ghobrial L, Gandhi PJ. Possible mechanisms of drug-induced aspirin and clopidogrel resistance. J Thromb Thrombolysis 2006; 22: 139–50
   PubMed Web of Science ®Google Scholar
• Vasilieva E, Kasyanova O, Shpektor A. CRP-plasma level and the efficacy of aspirin therapy in patients with coronary artery disease. Kardiologia 2006; 46: 66–7
   Google Scholar
• Rosenson RS, Tangney CC. Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA 1998; 279: 1643–50
   PubMed Web of Science ®Google Scholar
• Davignon J, Laaksonen R. Low-density lipoprotein-independent effects of statins. Curr Opin Lipidol. 1999; 10: 543–59
   PubMed Web of Science ®Google Scholar
• Hussein O, Rosenblat M, Schlezinger S, Keidar S, Aviram M. Reduced platelet aggregation after fluvastatin therapy is associated with altered platelet lipid composition and drug binding to the platelets. Br J Clin Pharmacol. 1997; 44: 77–84
   PubMedGoogle Scholar
• Haramaki N, Ikeda H, Takenaka K, Katoh A, Sugano R, Yamagishi S. Fluvastatin alters platelet aggregability in patients with hypercholesterolemia: Possible improvement of intraplatelet redox imbalance via HMG-CoA reductase. Arterioscler Thromb Vasc Biol. 2007; 27: 1471–7
   PubMedGoogle Scholar
• Wenaweser P, Windecker S, Billinger M, Cook S, Togni M, Meier B., et al. Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosis. Am J Cardiol. 2007; 99: 353–6
   PubMed Web of Science ®Google Scholar
• Born GVR. Quantitative investigation into aggregation of blood platelets. J Physiol (Lond) 1962; 162: 67–8
   Google Scholar
• O'Brien JR. Platelet aggregation. Part II. Some results of a new study. J Clin Pathol. 1962; 15: 452–5
   PubMed Web of Science ®Google Scholar
• Chen WH, Lee PY, Ng W, Tse HF, Lau CP. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment. J Am Coll Cardiol. 2004; 43: 1122–6
   PubMed Web of Science ®Google Scholar
• Borna C, Lazarowski E, Heusden C, Ohlin H, Erlinge D. Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels. Thromb J. 2005; 3: 10
   PubMedGoogle Scholar
• Andersen K, Hurlen M, Arnesen H, Seljeflot I: Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease. Thromb Res. 2002;108:37–42.
   PubMed Web of Science ®Google Scholar
• Lev EI, Patel RT, Maresh KJ, Guthikonda S, Granada J, DeLao T, et al. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance. J Am Coll Cardiol. 2006; 47: 27–33
   PubMed Web of Science ®Google Scholar
• Helgason CM, Bolin KM, Hoff JA, Winkler SR, Mangat A, Tortorice KL, et al. Development of aspirin resistance in persons with previous ischemic stroke. Stroke. 1994; 25: 2331–6
   PubMed Web of Science ®Google Scholar
• Grotemeyer KH, Scharafinski HW, Husstedt IW. Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients. Thromb Res. 1993; 71: 397–403
   PubMed Web of Science ®Google Scholar
• Tantry US, Bliden KP, Gurbel PA. Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation. J Am Coll Cardiol. 2005; 46: 1705–9
   PubMed Web of Science ®Google Scholar
• Borna C, Lazarowski E, Heusden C, Ohlin H, Erlinge D. Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels. Thromb J. 2005; 3: 10
   PubMedGoogle Scholar
• Gurbel PA, Becker RC, Mann KG, Steinhubl SR, Michelson AD. Platelet function monitoring in patients with coronary artery disease. JACC. 2007; 50: 1822–34
   Google Scholar
• Zimmermann N, Wenk A, Kim U, Kienzle U, Weber AA, Gams E., et al. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery. Circulation 2003; 108: 542–7
   PubMed Web of Science ®Google Scholar
• Kluft C. Identifying patients at risk of coronary vascular disease: the potential role of inflammatory markers. Eur Heart J 2004; 6(Suppl)C:21–27
   Google Scholar
• Piorkowski M, Fischer S, Stellbaum C, Jaster M, Martus P, Morguet AJ, et al. Treatment with ezetimibe plus low- dose atorvastatin compare? with higher-dose atorvastatin alone. JACC 2007; 49: 1035–42
   Google Scholar
• Tirnaksiz E, Pamukcu B, Oflaz H, Nisanci Y. Effect of high dose statin therapy on platelet function; statins reduce aspirin resistant platelet aggregation in patients with coronary heart disease. J Thromb Thrombolysis 2007; 24: 17917708
   Google Scholar
• Templin C, Schaefer A, Stumme B, Drexler H, von Depka M. Combined aspirin and clopidogrel resistance associated with recurrent coronary stent thrombosis. Clin Res Cardiol. 2006; 95: 122–6
   PubMedGoogle Scholar